Healthcare provider profile · identity verified

Mary Cyr, MD

Family Practice · PUYALLUP, WA · NPI 1447382601

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	249	74
Oxycodone Hcl	Oxycodone Hcl	225	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	220	30
Levothyroxine Sodium	Levothyroxine Sodium	197	49
Lisinopril	Lisinopril	192	60
Escitalopram Oxalate	Escitalopram Oxalate	151	40
Amlodipine Besylate	Amlodipine Besylate	147	46
Albuterol Sulfate Hfa	Albuterol Sulfate	144	44
Metoprolol Succinate	Metoprolol Succinate	143	39
Hydrochlorothiazide	Hydrochlorothiazide	116	35
Metformin Hcl	Metformin Hcl	109	29
Clonazepam	Clonazepam	99	14
Simvastatin	Simvastatin	94	23
Losartan Potassium	Losartan Potassium	90	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	89	suppressed
Citalopram Hbr	Citalopram Hydrobromide	88	19
Gabapentin	Gabapentin	88	24
Omeprazole	Omeprazole	87	25
Tramadol Hcl	Tramadol Hcl	86	suppressed
Tizanidine Hcl	Tizanidine Hcl	79	22
Alprazolam	Alprazolam	73	15
Trazodone Hcl	Trazodone Hcl	66	23
Rosuvastatin Calcium	Rosuvastatin Calcium	65	23
Potassium Chloride	Potassium Chloride	64	21
Symbicort	Budesonide/Formoterol Fumarate	63	11
Furosemide	Furosemide	61	16
Bupropion Xl	Bupropion Hcl	54	14
Ozempic	Semaglutide	54	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	54	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	13
Tamsulosin Hcl	Tamsulosin Hcl	48	18
Jardiance	Empagliflozin	45	11
Pantoprazole Sodium	Pantoprazole Sodium	44	14
Sertraline Hcl	Sertraline Hcl	43	12
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Carvedilol	Carvedilol	38	11
Ondansetron Odt	Ondansetron	38	12
Lorazepam	Lorazepam	37	suppressed
Celecoxib	Celecoxib	35	suppressed
Diazepam	Diazepam	35	suppressed
Ibandronate Sodium	Ibandronate Sodium	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	11
Mounjaro	Tirzepatide	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	12
Fluticasone Propionate	Fluticasone Propionate	30	11
Atenolol	Atenolol	29	suppressed
Eliquis	Apixaban	29	12
Methocarbamol	Methocarbamol	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Allopurinol	Allopurinol	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Topiramate	Topiramate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Prednisone	Prednisone	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Tradjenta	Linagliptin	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Fluconazole	Fluconazole	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Olanzapine	Olanzapine	21	suppressed
Colchicine	Colchicine	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Estradiol	Estradiol	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Baclofen	Baclofen	18	suppressed
Famotidine	Famotidine	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Zonisamide	Zonisamide	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Clonidine Hcl	Clonidine Hcl	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Azithromycin	Azithromycin	15	15
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Finasteride	Finasteride	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	12
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Adderall	Dextroamphetamine/Amphetamine	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error